Radial Artery Catheterization Kit; Model: AK-04020-C
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lots: 13F16H0430, 13F16M0224, 13F16M0242, 13F17F0150, 13F17F0475, 13F17G0240, 23F16E1193, 23F16F0476, 23F16G0085, 23F16H0013, 23F16H0680; Expiration dates: October 2018 through March 2020
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Arrow International Inc
- Reason for Recall:
- The povidone iodine prep pads included in certain kits and trays do not meet the requirements for a 36-month shelf life and should be labeled with a 24-month shelf life.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Radial Artery Catheterization Kit; Model: AK-04020-C
Product Codes/Lot Numbers:
Lots: 13F16H0430, 13F16M0224, 13F16M0242, 13F17F0150, 13F17F0475, 13F17G0240, 23F16E1193, 23F16F0476, 23F16G0085, 23F16H0013, 23F16H0680; Expiration dates: October 2018 through March 2020
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: Z-1283-2018
Related Recalls
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.